The administration of OAT-1746 or anti-PD-1 treatment did not change the percentage of microglia (CD11b+CD45low) and blood-derived macrophages (CD11b+CD45high) in experimental gliomas. The gene discussed is PDCD1; the disease is central nervous system cancer.